TrademarkDir
FLUPEMI
LIVE

Serial Number

98581130

Owner

GlaxoSmithKline Biologicals SA

Attorney

Christopher M. Hanes

Filing Date

Jun 3, 2024

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

FLUPEMI Trademark

Serial Number: 98581130

FLUPEMI is a trademark filed by GlaxoSmithKline Biologicals SA on June 3, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

GlaxoSmithKline Biologicals SA (140 trademarks)

Rue de l'Institut 89
B-1330 Rixensart , BE

Entity Type: 99

Trademark Details

Filing Date

June 3, 2024

Registration Date

Not Registered

Published for Opposition

October 7, 2025

Goods & Services

Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 2, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 9, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 8, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 8, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 8, 2025 GNSL
SUSPENSION LETTER WRITTEN
Apr 8, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 7, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 4, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 4, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 4, 2025 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 3, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 3, 2024 GNSL
SUSPENSION LETTER WRITTEN
Sep 3, 2024 CNSL
EXAMINER'S AMENDMENT ENTERED
Sep 3, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 3, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 3, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 3, 2024 CNEA
ASSIGNED TO EXAMINER
Aug 24, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 14, 2024 NWOS
NEW APPLICATION ENTERED
Jun 3, 2024 NWAP

Related Trademarks

More from this Owner

AS04

AS04

KYDVARIX

KYDVARIX

VAXBEMVO

VAXBEMVO

EASYVAX

EASYVAX

VYRIXFLU

VYRIXFLU

TRUSESFLU

TRUSESFLU